Mutation of fibulin-1 causes a novel syndrome involving the central nervous system and connective tissues

ABSTRACT Fibulin-1 is an extracellular matrix protein that has an important role in the structure of elastic fibers and basement membranes of various tissues. Using homozygosity mapping and

exome sequencing, we discovered a missense mutation, p.(Cys397Phe), in fibulin-1 in three patients from a consanguineous family presented with a novel syndrome of syndactyly, undescended

testes, delayed motor milestones, mental retardation and signs of brain atrophy. The mutation discovered segregated with the phenotype and was not found in 374 population-matched alleles.

The affected cysteine is highly conserved across vertebrates and its mutation is predicted to abolish a disulfide bond that defines the tertiary structure of fibulin-1. Our findings

emphasize the crucial role fibulin-1 has in development of the central nervous system and various connective tissues. SIMILAR CONTENT BEING VIEWED BY OTHERS NOVEL BIALLELIC _COL25A1_

VARIANTS BROADEN THE CLINICAL SPECTRUM FROM CONGENITAL CRANIAL DYSINNERVATION DISORDERS TO FETAL LETHAL PHENOTYPES Article Open access 29 March 2025 HETEROZYGOUS MUTATIONS IN THE

STRAITJACKET REGION OF THE LATENCY-ASSOCIATED PEPTIDE DOMAIN OF TGFB2 CAUSE CAMURATI–ENGELMANN DISEASE TYPE II Article 16 July 2024 A PATHOGENIC _UFSP2_ VARIANT IN AN AUTOSOMAL RECESSIVE

FORM OF PEDIATRIC NEURODEVELOPMENTAL ANOMALIES AND EPILEPSY Article Open access 20 January 2021 INTRODUCTION Fibulins are extracellular glycoproteins secreted in elastic fibers and basement

membranes of various tissues where they interact with several extracellular matrix (ECM) components. They have an important role in the assembly and stabilization of supramolecular ECM

complexes. The fibulin family is characterized by a tandem repeat of epidermal growth factor-like modules and a unique C-terminal fibulin-type module.1 Fibulin-1 (the first discovered member

of the fibulin family) is a highly conserved protein across metazoa.2 It is encoded by _FBLN1_ gene, which has four isoforms that differ in their ultimate exons. It is expressed in various

tissues such as vessel walls, cartilages, skin and lung. During development, it is prominently expressed in the neural crest cells, and is implicated in the morphogenesis of the cranial

neural crest-derived structures. It is implicated in tissue organogenesis in developing myotomes, endocardial cusion and digits of the developing limbs.1, 3 A translocation involving the

last exon of isoform D, t(12;22)(p11.2;q13.3) has been associated with polysyndactyly.4 Authors proposed that haploinsufficiency of isoform D was responsible for the limb malformation they

reported. Using a combination of homozygosity mapping and exome sequencing, we report the first point mutation of fibulin-1 and confirm its segregation in a novel autosomal recessive

syndrome affecting the development of the central nervous system and connective tissues. MATERIALS AND METHODS PATIENTS AND DNA SAMPLES Three affected individuals together with their parents

and siblings were recruited for the study at King Faisal Specialist Hospital and Research Center. Informed consents were obtained from all participating individuals, and 5–10 ml of venous

blood was drawn. DNA was extracted from lymphocytes using Puregene DNA extraction kit (Qiagen, Valencia, CA, USA). HOMOZYGOSITY MAPPING Cytogenetics Whole-Genome 2.7 M Arrays (Affymetrix,

Santa Clara, CA, USA) were used to genotype single-nucleotide polymorphisms (SNPs) in all affected individuals according to the manufacturer’s protocol. Homozygosity analysis was performed

using Chromosome Analysis Suite (Affymetrix). Shared homozygosity regions between the three affected individuals (II:1, II:2 and II:6) were exported to be used as a filter for exome sequence

variants. EXOME SEQUENCING A DNA sample from one of the affected individuals (II:2) was used for exome sequencing on SOLiD 4 instrument (Applied Biosystems, Foster City, CA, USA) using

Agilent (Santa Clara, CA, USA) SureSelect Human All Exon 50 MB kit with 50 × average coverage. Sequences were aligned using the NovoAlign aligner (NovoCraft, Selangor, Malaysia) and variants

were called using The Genome Analysis Toolkit (Broad Institute, Cambridge, MA, USA). Cut-off values for quality scores were: QUAL >50 and DQ >8. PCR AND SANGER SEQUENCING The segment

surrounding the c.1190G>T mutation was PCR amplified for all family members. Amplicons were then sequenced using BigDye Terminator sequencing kit (Applied Biosystems) and run on an

ABI3130xl genetic analyzer (Applied Biosystems). Sequencher software (Gene Codes Corporation, Ann Arbor, MI, USA) was used to align sequence data to reference sequence (GenBank:NM_006486).

The detected variant has been submitted to ClinVar Database (URL: http://www.ncbi.nlm.nih.gov/clinvar/). RESULTS CLINICAL PRESENTATION Three affected children of second-cousin parents

(Figure 1) presented with signs of limb malformation and/or undescended testes at birth and later showed abnormal developmental milestones. INDIVIDUAL II:1 Individual II:1 presented with

syndactyly in her left hand at birth. She had delayed crawling and walked independently at the age of 18 months. She was diagnosed with infantile spasm with corresponding EEG changes at the

age of 2 years. The spasm resolved with corticosteroid therapy. She also suffered from bilateral hip dislocation and required bilateral hip replacement. At age 23, she started to have

stiffness and numbness in the left leg. MRI of the brain showed cortical atrophy and few scattered white matter lesions (Figure 2a). Cervical spine MRI showed compression at C3 and C4

levels, and syringomyelia at lower thoracic region (Figure 2b and c). She underwent cervical spine decompression surgery successfully but remained with mild leg spasticity. Cognitive

milestones were normal. She had normal vision. INDIVIDUAL II:2 Individual II:2 presented with bilateral foot syndactyly and undescended testes at birth. He suffered from static

encephalopathy and could not read or write. Speech was spastic and dysarthric with pseudobulbar signs. He had dystonic and spastic posturing of arms and legs with impaired postural reflexes

and suffered from moderate mental retardation. Upon ophthalmoscopic examination, he was found to have macular degeneration evidenced by subretinal fibrosis and choroidal neovascularization.

Brain MRI showed generalized hemispheric atrophy. Brain MR angiography showed no abnormailities in brain vessels. Echocardiography did not show changes in the heart or heart great vessels.

INDIVIDUAL II:6 Individual II:6 presented with bilateral undescended testes with no syndactyly, but suffered from delayed speech and motor milestones. He was able to walk with walker but he

required bilateral tendotomies and release of the thigh adductor muscles to relieve spasticity. At the age of 16 years, he was ambulatory on powered wheelchair. He had dysarthria, drooling

and pseudobulbar signs. He suffered from moderate mental retardation. MRI of the brain revealed moderate brain atrophy. He showed no signs of macular degeneration. DETECTION OF A POINT

MUTATION IN _FBLN1_ USING HOMOZYGOSITY MAPPING AND EXOME SEQUENCING Based on the autosomal recessive inheritance pattern, rarity of the syndrome and the fact that parents are second cousins,

we hypothesized the existence of a founder mutation in a common ancestry of both parents. Therefore, we looked for autozygous regions within affected individual genomes using high-density

whole-genome SNP genotyping arrays. Results were scanned for segments of homozygosity shared by the three affected individuals (where the potential mutation is expected). We found that these

segments accounted for about 6% of the genome (∼180 Mbp). Next, we sequenced the exome of one of the affected individuals (II:2) and used the following criteria to filter the 32 000+

variants detected by exome sequencing: (1) within shared homozygosity segments, (2) not in 1000 genome project database, (3) non-synonymous coding and (4) homozygous. These criteria

successfully filtered out all but a single variant (c.1190G>T) on exon 10 of _FBLN1_ gene located on chromosome 22. This variant results in the substitution of a cysteine residue at

position 397 of fibulin-1 protein by phenylalanine, p.(Cys397Phe). We confirmed this variant using Sanger sequencing (Figure 3a) and genotyped family members for this variant. Genotypes

perfectly segregated with the phenotype (Figure 1). In addition, to rule out a possible SNP, we sequenced 374 population-matched alleles and all were negative for this variant. NATURE OF THE

MUTATION AND PREDICTED EFFECT ON PROTEIN STRUCTURE The protein encoded by _FBLN1_ (fibulin-1) is an ECM protein characterized by nine tandem EGF-like domains that are present in many

extracellular proteins and have crucial role in their diverse functions. These domains are 40-amino-acids long and characterized by six conserved cysteine residues that form three disulfide

bonds, and determine the tertiary structure of the domain.5 Many EGF-like domains need to bind calcium for their biological function. The mutation we detected in fibulin-1 affects the sixth

cysteine residue of the calcium-binding EGF-like domain number five. This cysteine is highly conserved across vertebrates (Figure 3b), and its substitution is predicted to significantly

affect the structure of the fifth EGF-like domain (a shared domain between the four fibulin-1 isoforms), as it abolishes the disulfide bond between the fifth and sixth cysteine residues of

this domain (Figures 3c and 4). As the function of fibulin-1 is not well understood, it is difficult to determine the functional effect of this mutation; however, based on the role this

specific cysteine residue has in determining protein structure and its high level of conservation, it is expected to be detrimental to the function of fibulin-1. This detrimental effect is

further supported by the high score (1.0) for this mutation obtained from the PolyPhen-2 algorithm.6 DISCUSSION Several hereditary disorders have been associated with mutations in fibulin

family proteins. Examples are cutis laxa with fibulin-4 and fibulin-5; age-related macular degeneration with fibulin-3, fibulin-5 and fibulin-6; and aortic aneurysm and arachnodactyly with

fibulin-4.7, 8, 9, 10, 11 Here we have shown that a mutation affecting a highly conserved cysteine residue in fibulin-1 leads to multiple overlapping phenotypes in three affected siblings,

including syndactyly, cryptorchidism, delayed motor milestones, pseudobulbar signs, mental retardation and evidence of brain atrophy, and compression of spinal cord in MRI scans. These

phenotypes involve multiple systems and (with the exception of macular degeneration in individual II:2) are unique to fibulin-1, which indicates a specific role for fibulin-1 in ECM assembly

and function. The early age of onset indicates the importance of fibulin-1 in intrauterine development of the brain and connective tissues. One of the associated symptoms, syndactyly, has

been reported previously in a family with translocation involving the D isoform, it was the only manifestation in that family and was dominantly transmitted.4 However, none of the parents or

carriers in our case showed syndactyly. This could be explained by dominant negative effect of the translocation mutation compared with the point mutation reported here, which is more

likely consistent with loss of function effect. Also, these data may indicate a specific role of isoform D in limb development. Although little is known about the function of the EGF-like

domains of fibulins, the fifth EGF-like domain of fibulin-1 is a calcium-binding domain that has been shown to have a role in the localization of the protein and its self-interaction, as

well as interaction with other proteins such as hemicentin.12, 13 Our approach of homozygosity mapping and exome sequencing showed how robust this method is in discovering the genetic defect

in families with high consanguinity. Limiting our screening to the shared homozygosity regions has helped us rule out >99% of detected variants. Further data filtering for only coding

homozygous variants lead us to a single variant that was later confirmed by Sanger sequencing method. In conclusion, we used the combined approach of homozygosity mapping and exome

sequencing to discover the genetic defect underlying a novel syndrome affecting the central nervous system, connective and other tissues. We showed how this approach was successful to

pinpoint a single variant. We also showed that the discovered mutation affects a highly conserved residue and potentially affects the tertiary structure of fibulin-1. REFERENCES * de Vega S,

Iwamoto T, Yamada Y : Fibulins: multiple roles in matrix structures and tissue functions. _Cell Mol Life Sci_ 2009; 66: 1890–1902. Article  CAS  Google Scholar  * Segade F : Molecular

evolution of the fibulins: implications on the functionality of the elastic fibulins. _Gene_ 464: 17–31. Article  CAS  Google Scholar  * Cooley MA, Kern CB, Fresco VM _et al_: Fibulin-1 is

required for morphogenesis of neural crest-derived structures. _Dev Biol_ 2008; 319: 336–345. Article  CAS  Google Scholar  * Debeer P, Schoenmakers EF, Twal WO _et al_: The fibulin-1 gene

(FBLN1) is disrupted in a t(12;22) associated with a complex type of synpolydactyly. _J Med Genet_ 2002; 39: 98–104. Article  CAS  Google Scholar  * Appella E, Weber IT, Blasi F : Structure

and function of epidermal growth factor-like regions in proteins. _FEBS Lett_ 1988; 231: 1–4. Article  CAS  Google Scholar  * Adzhubei IA, Schmidt S, Peshkin L _et al_: A method and server

for predicting damaging missense mutations. _Nat Meth_ 2010; 7: 248–249. Article  CAS  Google Scholar  * Hucthagowder V, Sausgruber N, Kim KH, Angle B, Marmorstein LY, Urban Z : Fibulin-4: a

novel gene for an autosomal recessive cutis laxa syndrome. _Am J Hum Genet_ 2006; 78: 1075–1080. Article  CAS  Google Scholar  * Loeys B, Van Maldergem L, Mortier G _et al_: Homozygosity

for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa. _Hum Mol Genet_ 2002; 11: 2113–2118. Article  CAS  Google Scholar  * Schultz DW, Klein ML, Humpert AJ _et

al_: Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. _Hum Mol Genet_ 2003; 12: 3315–3323.

Article  CAS  Google Scholar  * Stone EM, Braun TA, Russell SR _et al_: Missense variations in the fibulin 5 gene and age-related macular degeneration. _N Engl J Med_ 2004; 351: 346–353.

Article  CAS  Google Scholar  * Stone EM, Lotery AJ, Munier FL _et al_: A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. _Nat Genet_

1999; 22: 199–202. Article  CAS  Google Scholar  * Muriel JM, Dong C, Vogel BE : Distinct regions within fibulin-1D modulate interactions with hemicentin. _Exp Cell Res_ 2012; 318:

2543–2547. Article  CAS  Google Scholar  * Tran H, VanDusen WJ, Argraves WS : The self-association and fibronectin-binding sites of fibulin-1 map to calcium-binding epidermal growth

factor-like domains. _J Biol Chem_ 1997; 272: 22600–22606. Article  CAS  Google Scholar  * Keshava Prasad TS, Goel R, Kandasamy K _et al_: Human protein reference database—2009 update.

_Nucleic Acids Res_ 2009; 37: D767–D772. Article  CAS  Google Scholar  * Madej T, Addess KJ, Fong JH _et al_: MMDB: 3D structures and macromolecular interactions. _Nucleic Acids Res_ 2012;

40: D461–D464. Article  CAS  Google Scholar  * Lu HS, Chai JJ, Li M, Huang BR, He CH, Bi RC : Crystal structure of human epidermal growth factor and its dimerization. _J Biol Chem_ 2001;

276: 34913–34917. Article  CAS  Google Scholar  Download references ACKNOWLEDGEMENTS We thank participating patients and their family for being cooperative throughout the study. We also

thank all colleagues who contributed to this work by providing their valuable advice on experimental methods. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of Neurosciences, King

Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia Saeed Bohlega * Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia Huda

Al-Ajlan & Amr Al-Saif * Laboratory of Neurogenetics, National Institutes of Health, Bethesda, MD, USA Amr Al-Saif Authors * Saeed Bohlega View author publications You can also search

for this author inPubMed Google Scholar * Huda Al-Ajlan View author publications You can also search for this author inPubMed Google Scholar * Amr Al-Saif View author publications You can

also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Amr Al-Saif. ETHICS DECLARATIONS COMPETING INTERESTS The authors declare no conflict of interest.

RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Bohlega, S., Al-Ajlan, H. & Al-Saif, A. Mutation of fibulin-1 causes a novel syndrome involving the

central nervous system and connective tissues. _Eur J Hum Genet_ 22, 640–643 (2014). https://doi.org/10.1038/ejhg.2013.210 Download citation * Received: 08 May 2013 * Revised: 01 August 2013

* Accepted: 16 August 2013 * Published: 02 October 2013 * Issue Date: May 2014 * DOI: https://doi.org/10.1038/ejhg.2013.210 SHARE THIS ARTICLE Anyone you share the following link with will

be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt

content-sharing initiative KEYWORDS * FBLN1 * fibulins * homozygosity mapping * exome sequencing * neurodegenerative disease